Table 2. Effect of FJH-UBS administration on the body weight, liver weight, and uterus weight in ovariectomized mice.

Variables	Sham	OVX	OVX+FU	OVX+SI
Initial body weight (g)	31.2 ± 1.0	39.7 ± 0.9***	39.8 ± 1.1	39.5 ± 0.5
Final body weight (g)	36.5 ± 1.9	48.1 ± 1.2***	44.3 ± 1.5	44.8 ± 0.9
Body weight gain (g)	5.3 ± 1.1	8.4 ± 0.4***,a	4.5 ± 0.4b	5.3 ± 0.6b
Liver weight (g)	1.50 ± 0.07	1.95 ± 0.08***,a	1.75 ± 0.06b	1.65 ± 0.06b
Uterus weight (g)	0.248 ± 0.021	0.062 ± 0.016***	0.087 ± 0.017	0.084 ± 0.016

Values are expressed as the mean ± SE (n = 10).

Sham, sham-operated group; OVX, ovariectomized group; OVX+FU, ovariectomized and 80 mg/kg body weight FJH-UBS-treated group; OVX+SI, ovariectomized and 5 mg/kg body weight soy isoflavones (a positive control)-treated group.

^***P < 0.001 significantly different from the Sham group. Mean without a common letter differs among the OVX, OVX+FU, and OVX+SI groups at P < 0.05.